Skip to content
Sunshine Biopharma Logo
  • Home
  • SEC Filings
  • Press Releases
  • Investor FAQ
  • Latest News
Menu Close
  • Home
  • SEC Filings
  • Press Releases
  • Investor FAQ
  • Latest News

Blog

  1. Home>
  2. Sec Filings>
  3. SEC Filing 10-Q | Second Quarter Report
SEC Filing 10-Q | Second Quarter Report

SEC Filing 10-Q | Second Quarter Report

  • Post author:Sunshine Biopharma News
  • Post published:August 3, 2022
  • Post category:Sec Filings

Available only in PDF version. Click HERE to open.

Tags: Sec-filing

Read more articles

Previous PostSEC Filing Prospectus Rule 424(b)(3)

You Might Also Like

Read more about the article SEC Filing Prospectus Rule 424(b)(3)

SEC Filing Prospectus Rule 424(b)(3)

May 22, 2022

Recent Posts

  • SUNSHINE BIOPHARMA ENTERS INTO A COLLABORATION AGREEMENT WITH A LEADING LIPID NANOPARTICLE FORMULATION COMPANY FOR ITS K1.1 ANTICANCER mRNA PROJECT
  • SUNSHINE BIOPHARMA ANNOUNCES THE ACQUISITION OF NORA PHARMA, ADDING $10.7 MILLION IN REVENUE
  • SUNSHINE BIOPHARMA FILES ITS SECOND QUARTER REPORT WITH THE SEC
  • SEC Filing 10-Q | Second Quarter Report
  • SUNSHINE BIOPHARMA INCREASES SUPPORT FOR ANTI-CORONAVIRUS COLLABORATIVE RESEARCH WITH THE UNIVERSITY OF ARIZONA

Archives

  • November 2022
  • October 2022
  • August 2022
  • July 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • January 2022
  • December 2021
  • November 2021
  • October 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • June 2020
  • November 2019
  • October 2019
  • September 2019
  • May 2019
  • March 2019
  • February 2019
  • December 2018
© 2009-2022 SUNSHINE BIOPHARMA INC. All Rights Reserved.